Gong Zhang

Gong Zhang

Auto-generated profile, based on publicly available information

Gong Zhang

Department of Radiotherapy, Shanxi Provincial People's Hospital, Shanxi Medical University, Taiyuan, China

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2013 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
XLXi-Qing Li
Xi-Qing Li
XYXing-Long Yang
Xing-Long Yang
GZGong Zhang
Gong Zhang
SWSi-Pei Wu
Si-Pei Wu
XDXu-Bing Deng
Xu-Bing Deng
GXGuang-Hui Xiao
Guang-Hui Xiao
Background: Although the prognostic roles of β-catenin expression in non-small cell lung cancer (NSCLC) have been reported in several immunohistochemical (IHC) studies, the results were not consistent because some studies lack sufficient number of the positive cases or did not evaluate the subcellular localization features of the protein. Method: In this study, we have evaluated the expression levels and subcellular localization of β-catenin and Nanog proteins IHC staining in tissue specimens from 309 patients with NSCLC, and explored their association with clinicopathological features and patient outcome. Results: We showed that patients with negative expression of membranous beta-catenin had a trend towards shorter survival (p=0.064) than those with positive expression. In contrast to previous studies, we found that increased expression of either cytoplasmic or nuclear β-catenin was strongly associated with poor prognosis and was an independent prognosticator for overall survival (p <0.01). We further found that NSCLC cells frequently exhibited an abundance of nuclear Nanog protein which was significantly correlated with nuclear β-catenin expression (p <0.01) and poor prognosis (p <0.01). Interestingly, immunofluorescent staining results revealed that increased expression of Nanog and nuclear translocation of β-catenin occurred concomitantly in response to epidermal growth factor receptor(EGFR) signaling in A549 and H23 cells. Furthermore, western blot analysis show that nuclear β-catenin rather than cytoplasmic β-catenin expression in the A549 and H23 cells can be enhanced by adding EGF, Nanog expression in the A549 and H23 cells with knockdown of β-catenin can not be obviously enhanced by adding EGF. Conclusion: We propose that evaluation of subcellular localization of β-catenin and Nanog expression is of clinical significance for patients with NSCLC.

1 September 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
HGHai Gao
Hai Gao
NGNana Gong
Nana Gong
ZMZebin Ma
Zebin Ma
XMXiaobo Miao
Xiaobo Miao
JCJinchun Chen
Jinchun Chen
GZGong Zhang
Gong Zhang

1 July 2017 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
GZGong Zhang
Gong Zhang
WWWenjun Wang
Wenjun Wang
CYChunxiao Yao
Chunxiao Yao
JRJinjin Ren
Jinjin Ren
SZShuping Zhang
Shuping Zhang
MHMuyuan Han
Muyuan Han

15 February 2019 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
YLYaoyong Lu
Yaoyong Lu
YLYingying Liang
Yingying Liang
XZXin Zheng
Xin Zheng
XDXubin Deng
Xubin Deng
WHWendong Huang
Wendong Huang
GZGong Zhang
Gong Zhang
Aberrant EVI1 expression is frequently reported in cancer studies; however, its role in nasopharyngeal carcinoma (NPC) has not been examined in detail. The aim of the present study is to investigate the involvement of EVI1 in progression and prognosis of NPC. RT-PCR, immunohistochemistry and western blot assays were used to examine the expression of EVI1 in NPC tissues and cell lines. Fluorescence in situ hybridization assay was used to examine the amplification of EVI1 in NPC tissues. The biological effect of EVI1 was determined by both in vitro and in vivo studies. The dual-luciferase reporter assay was performed to confirm that EVI1 bind at E-cadherin andβ-catenin promoters. The ChIP, EMSA, and coimmunoprecipitation combined with mass spectrometry assays were used to analyze the EVI1 regulated proteins. EVI1 expression level was up-regulated in NPC tissues and cell lines. EVI1 was amplificated in NPC tissues. We observed that EVI1 down-regulation decreased the cell proliferation and invasive capacity of NPC cells in vitro and in vivo. EVI1, snail, and HDAC1 formed a co-repressor complex to repress E-cadherin expression and ultimately contributed to epithelial mesenchymal transition (EMT) phenotype in NPC cells. In another way, EVI1 directly bound at β-catenin promoter and activated its expression. β-catenin mediated EVI1’s function on cancer stem cells (CSCs) properties. EVI1 up-regulation predicted unfavorable prognosis and contributed to chemo/radio-resistance in NPC cells. Finally, we constructed arsenic trioxide-loaded nanoparticles (ALNPs) and revealed that ALNPs exerted anti-tumor effect in NPC cells. Our data indicated that EVI1 played an oncogenic role in NPC growth and metastasis and that EVI1 might serve as a novel molecular target for the treatment of NPC.

18 August 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
GZGong Zhang
Gong Zhang
WWWenjun Wang
Wenjun Wang
CYChunxiao Yao
Chunxiao Yao
SZShuping Zhang
Shuping Zhang
LLLili Liang
Lili Liang
LLLei Li
Lei Li
Radiation-resistant cancer stem-like cell properties are regulated by PTEN through the activity of nuclear -catenin in nasopharyngeal carcinoma Radiation-resistant cancer stem-like cell properties are regulated by PTEN through the activity of nuclear β-catenin in nasopharyngeal carcinoma

24 August 2012 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
YXYou-Ke Xie
You-Ke Xie
SHShao-Fen Huo
Shao-Fen Huo
GZGong Zhang
Gong Zhang
FZFu Zhang
Fu Zhang
ZLZu-Ping Lian
Zu-Ping Lian
CJChuan Jin
Chuan Jin